FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041567325> ?p ?o ?g. }

• W2041567325 endingPage "971" @default.
• W2041567325 startingPage "964" @default.
• W2041567325 abstract "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Increased levels of ADMA cause impaired vasodilation, leading to endothelial dysfunction and a higher risk for cardiovascular events. In patients with a chronic kidney disease, increased ADMA levels are reported to play a role in the pathogenesis of accelerated atherosclerosis and are an independent risk marker leading to end-stage renal disease and mortality. Circulating ADMA is metabolized by the action of dimethylarginine dimethylamino hydrolase (DDAH) and DDAH2 isoform is the most prevalent in tissues expressing endothelial NOS. DDAH and NOS are co-expressed in the same kidney regional sites supporting the hypothesis that a strict and specific regulation of intracellular ADMA levels is crucial for NO generation in the kidney. Starting from these findings, the study aims to investigate the role of DDAH2 gene promoter polymorphism at position -1151 A/C in determining the levels of ADMA in type 2 diabetic patients (T2DM) with chronic renal impairment.Three groups of carefully selected subjects of both sexes were enrolled and compared. The first group (control subjects) comprised 286 non-diabetic subjects (mean age 55.8 ± 11.4 years), the second group (T2DM uncomplicated subjects) was made up of 322 T2DM subjects without complications (mean age 64.9 ± 9.6 years) whereas the third group (T2DM CRF subjects) included 110 T2DM patients with chronic renal impairment. The rs805304 DDAH2-1151 A/C promoter polymorphism was determined by a polymerase chain reaction-restriction fragment length polymorphism approach. Results T2DM CRF subjects showed significant increased plasma levels of ADMA with respect to those of T2DM uncomplicated subjects and control subjects (0.51 versus 0.39 versus 0.37 μmol/L, P = 0.002, respectively). Analysis of variance showed an interaction between DDAH2-1151 C carrier and groups on ADMA plasma levels (F = 4.36; P < 0.05). ADMA plasma levels were also dependent on groups (F = 4.96; P < 0.01).Our work demonstrates that rs805304 DDAH2-1151 polymorphism plays a central role in determining ADMA in diabetic renal impairment, where patients with DDAH2-1151 C carriers showed the highest ADMA levels. This unfavourable genetic profile is highlighted by pathological kidney conditions such as diabetic CRF. These findings could open new insights on the pathways involving ADMA/DDAH/NOS in the development and progression of chronic renal impairment and therefore of the other micro- macrovascular diabetic complications." @default.
• W2041567325 created "2016-06-24" @default.
• W2041567325 creator A5002382709 @default.
• W2041567325 creator A5002840335 @default.
• W2041567325 creator A5004092932 @default.
• W2041567325 creator A5027639037 @default.
• W2041567325 creator A5036145205 @default.
• W2041567325 creator A5040118133 @default.
• W2041567325 creator A5044764461 @default.
• W2041567325 creator A5047608830 @default.
• W2041567325 creator A5052338213 @default.
• W2041567325 creator A5078302741 @default.
• W2041567325 creator A5082046796 @default.
• W2041567325 date "2012-11-04" @default.
• W2041567325 modified "2023-10-07" @default.
• W2041567325 title "Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects" @default.
• W2041567325 cites W1980228925 @default.
• W2041567325 cites W1986656566 @default.
• W2041567325 cites W2015814983 @default.
• W2041567325 cites W2025891985 @default.
• W2041567325 cites W2037655806 @default.
• W2041567325 cites W2058385357 @default.
• W2041567325 cites W2064749533 @default.
• W2041567325 cites W2066921335 @default.
• W2041567325 cites W2070993775 @default.
• W2041567325 cites W2076065477 @default.
• W2041567325 cites W2083164971 @default.
• W2041567325 cites W2115421882 @default.
• W2041567325 cites W2116430084 @default.
• W2041567325 cites W2117156673 @default.
• W2041567325 cites W2119861336 @default.
• W2041567325 cites W2124279221 @default.
• W2041567325 cites W2132464590 @default.
• W2041567325 cites W2134310604 @default.
• W2041567325 cites W2136960413 @default.
• W2041567325 cites W2139327777 @default.
• W2041567325 cites W2146571493 @default.
• W2041567325 cites W2148531805 @default.
• W2041567325 cites W2151554519 @default.
• W2041567325 cites W2154388708 @default.
• W2041567325 cites W2164479543 @default.
• W2041567325 cites W2404761955 @default.
• W2041567325 cites W4232138652 @default.
• W2041567325 cites W4234756224 @default.
• W2041567325 doi "https://doi.org/10.1093/ndt/gfs516" @default.
• W2041567325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23129820" @default.
• W2041567325 hasPublicationYear "2012" @default.
• W2041567325 type Work @default.
• W2041567325 sameAs 2041567325 @default.
• W2041567325 citedByCount "15" @default.
• W2041567325 countsByYear W20415673252013 @default.
• W2041567325 countsByYear W20415673252016 @default.
• W2041567325 countsByYear W20415673252017 @default.
• W2041567325 countsByYear W20415673252018 @default.
• W2041567325 countsByYear W20415673252019 @default.
• W2041567325 countsByYear W20415673252020 @default.
• W2041567325 countsByYear W20415673252021 @default.
• W2041567325 countsByYear W20415673252022 @default.
• W2041567325 crossrefType "journal-article" @default.
• W2041567325 hasAuthorship W2041567325A5002382709 @default.
• W2041567325 hasAuthorship W2041567325A5002840335 @default.
• W2041567325 hasAuthorship W2041567325A5004092932 @default.
• W2041567325 hasAuthorship W2041567325A5027639037 @default.
• W2041567325 hasAuthorship W2041567325A5036145205 @default.
• W2041567325 hasAuthorship W2041567325A5040118133 @default.
• W2041567325 hasAuthorship W2041567325A5044764461 @default.
• W2041567325 hasAuthorship W2041567325A5047608830 @default.
• W2041567325 hasAuthorship W2041567325A5052338213 @default.
• W2041567325 hasAuthorship W2041567325A5078302741 @default.
• W2041567325 hasAuthorship W2041567325A5082046796 @default.
• W2041567325 hasBestOaLocation W20415673251 @default.
• W2041567325 hasConcept C126322002 @default.
• W2041567325 hasConcept C134018914 @default.
• W2041567325 hasConcept C2777468819 @default.
• W2041567325 hasConcept C2777622882 @default.
• W2041567325 hasConcept C2778653478 @default.
• W2041567325 hasConcept C2779877776 @default.
• W2041567325 hasConcept C2780091579 @default.
• W2041567325 hasConcept C2780942790 @default.
• W2041567325 hasConcept C2780972559 @default.
• W2041567325 hasConcept C515207424 @default.
• W2041567325 hasConcept C519581460 @default.
• W2041567325 hasConcept C54355233 @default.
• W2041567325 hasConcept C71924100 @default.
• W2041567325 hasConcept C86803240 @default.
• W2041567325 hasConceptScore W2041567325C126322002 @default.
• W2041567325 hasConceptScore W2041567325C134018914 @default.
• W2041567325 hasConceptScore W2041567325C2777468819 @default.
• W2041567325 hasConceptScore W2041567325C2777622882 @default.
• W2041567325 hasConceptScore W2041567325C2778653478 @default.
• W2041567325 hasConceptScore W2041567325C2779877776 @default.
• W2041567325 hasConceptScore W2041567325C2780091579 @default.
• W2041567325 hasConceptScore W2041567325C2780942790 @default.
• W2041567325 hasConceptScore W2041567325C2780972559 @default.
• W2041567325 hasConceptScore W2041567325C515207424 @default.
• W2041567325 hasConceptScore W2041567325C519581460 @default.
• W2041567325 hasConceptScore W2041567325C54355233 @default.
• W2041567325 hasConceptScore W2041567325C71924100 @default.

• next